Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$0.0050
0.00%
(0.00) 1D
ኦክቶ 19, 12:14:10 ከሰዓት ጂ ኤም ቲ-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285.49 ሺ
Avg. vol.
839.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
13.69
Shares outstanding
57.07 ሚ
Mkt. cap
285.49 ሺ
Avg. vol.
839.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
13.69
Shares outstanding
57.07 ሚ
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
Headquartersቫንኩቨር, ብሪቲሽ ኮለምቢያ, ካናዳ
SectorBiotechnology
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.77 ሺ
2.06 ሺ
2.95 ሺ
1.58 ሺ
Operating expense
34.77 ሺ
2.06 ሺ
2.95 ሺ
1.58 ሺ
Total operating expenses
34.77 ሺ
2.06 ሺ
2.95 ሺ
1.58 ሺ
Operating income
-34.77 ሺ
-2.06 ሺ
-2.95 ሺ
-1.58 ሺ
Other non operating income
-2.27 ሺ
-1.16 ሺ
-10.54 ሺ
-1.91 ሺ
EBT including unusual items
-39.64 ሺ
-5.83 ሺ
-16.55 ሺ
-6.82 ሺ
EBT excluding unusual items
-39.64 ሺ
-5.83 ሺ
-16.55 ሺ
-6.82 ሺ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.64 ሺ
-5.83 ሺ
-16.55 ሺ
-6.82 ሺ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.61 ሺ
-2.61 ሺ
-3.06 ሺ
-3.33 ሺ
Net interest expenses
-2.61 ሺ
-2.61 ሺ
-3.06 ሺ
-3.33 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.38 ሺ
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች